Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 01 • 04:00PM ET

13.71

+0.31 2.31 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: VRTX REGN AMGN BIIB GILD INCY ILMN ALNY NBIX ONC

| Held by: VTI VXF ITOT IWC MEDI DFAS DFMC TMED DXUV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.10	Insider Own	10.04%	Shs Outstand	26.71M	Perf Week	-1.51%
Market Cap	366.25M	Forward P/E	-	EPS next Y	-3.85	Insider Trans	-2.70%	Shs Float	24.03M	Perf Month	-17.90%
Enterprise Value	270.31M	PEG	-	EPS next Q	-1.03	Inst Own	76.65%	Short Float	21.80%	Perf Quarter	-9.27%
Income	-78.26M	P/S	6104.19	EPS this Y	35.39%	Inst Trans	41.76%	Short Ratio	7.51	Perf Half Y	-24.00%
Sales	0.06M	P/B	3.06	EPS next Y	-2.09%	ROA	-58.31%	Short Interest	5.24M	Perf YTD	-24.50%
Book/sh	4.49	P/C	3.72	EPS next 5Y	14.09%	ROE	-72.43%	52W High	20.72 -33.83%	Perf Year	172.02%
Cash/sh	3.68	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-91.98%	52W Low	3.39 304.42%	Perf 3Y	-98.15%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-483.05%	Volatility	10.10% 8.88%	Perf 5Y	-99.85%
Dividend TTM	-	EV/Sales	4505.19	EPS Y/Y TTM	95.62%	Oper. Margin	-123601.69%	ATR (14)	1.21	Perf 10Y	-99.88%
Dividend Ex-Date	-	Quick Ratio	8.14	Sales Y/Y TTM	-86.62%	Profit Margin	-132642.37%	RSI (14)	45.59	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.14	EPS Q/Q	78.04%	SMA20	-3.32%	Beta	0.79	Target Price	40.50
Payout	-	Debt/Eq	0.03	Sales Q/Q	-69.27%	SMA50	-9.87%	Rel Volume	1.03	Prev Close	13.40
Employees	33	LT Debt/Eq	0.02	Earnings	Mar 23 BMO	SMA200	-3.75%	Avg Volume	697.48K	Price	13.71
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	47.48% -	Trades		Volume	720,704	Change	2.31%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)